Drastic Effect of GermlineTP53Missense Mutations in Li-Fraumeni Patients-Reference-Cited by-同舟云学术

Drastic Effect of GermlineTP53Missense Mutations in Li-Fraumeni Patients

Published:2013-03 Issue:3 Volume:34 Page:453-461
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Zerdoumi Yasmine¹,Aury-Landas Juliette¹,Bonaïti-Pellié Catherine²,Derambure Céline³,Sesboüé Richard¹,Renaux-Petel Mariette¹,Frebourg Thierry,Bougeard Gaëlle¹,Flaman Jean-Michel¹

Affiliation:

1. Inserm U1079, Institute for Research and Innovation in Biomedicine (IRIB); University of Rouen; Rouen; France

2. Inserm U669; University of Paris Sud; Villejuif; France

3. Inserm U905, Institute for Research and Innovation in Biomedicine (IRIB); University of Rouen; Rouen; France

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference43 articles.

1. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families;Achatz;Cancer Lett,2007

2. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene;Bougeard;Oncogene,2003

3. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families;Bougeard;J Med Genet,2008

4. A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage;Camplejohn;Br J Cancer,1995

5. Sensitivity and predictive value of criteria for p53 germline mutation screening;Chompret;J Med Genet,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability;Molecular Systems Biology;2024-04-05

2. Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne;Cancer Medicine;2024-01-17

3. Germline Predisposition to Myelodysplastic Syndromes;The Cancer Journal;2023-05

4. Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis;Cell Death Discovery;2023-04-14

5. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability;2022-03-14